Abstract
This review intends to provide a comprehensive coverage of the various patents, published or issued, since 2007 on live or attenuated bacteria as potential anticancer agents, as well as microbial products including toxins, enzymes, antibiotics, various proteins and peptides as well as other small molecular weight products. Below is a list of such published/ issued patents and a summary of the main contents of many such patents.
Keywords: Anticancer drugs, bacteria, bacterial produts, cancer, patents, Tumor Growth, Therapeutic Vaccine Vector, Uterine Cancer, Oncopathic Therapy, Colon Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery
Title: Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents
Volume: 7 Issue: 1
Author(s): Arsenio M. Fialho, Nuno Bernardes and Ananda M. Chakrabarty
Affiliation:
Keywords: Anticancer drugs, bacteria, bacterial produts, cancer, patents, Tumor Growth, Therapeutic Vaccine Vector, Uterine Cancer, Oncopathic Therapy, Colon Cancer Cells
Abstract: This review intends to provide a comprehensive coverage of the various patents, published or issued, since 2007 on live or attenuated bacteria as potential anticancer agents, as well as microbial products including toxins, enzymes, antibiotics, various proteins and peptides as well as other small molecular weight products. Below is a list of such published/ issued patents and a summary of the main contents of many such patents.
Export Options
About this article
Cite this article as:
M. Fialho Arsenio, Bernardes Nuno and M. Chakrabarty Ananda, Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents, Recent Patents on Anti-Cancer Drug Discovery 2012; 7 (1) . https://dx.doi.org/10.2174/157489212798357949
DOI https://dx.doi.org/10.2174/157489212798357949 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNAs in Abdominal Aortic Aneurysm
Current Vascular Pharmacology Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Dietary Phytochemicals in Cancer Signalling Pathways: Role of miRNA Targeting
Current Medicinal Chemistry iTRAQ-Based Quantitative Proteomics Analysis Reveals the Invasion Mechanism of <i>Spiroplasma eriocheiris</i> in 3T6 Cells
Current Proteomics Apelin in the Control of Body Fluid Homeostasis and Cardiovascular Functions
Current Pharmaceutical Design Formulation of Thiamine-Laden Chitosan Nanosphere for Nutraceutical Application
Current Bioactive Compounds Molecular Mechanisms of Renal Blood Flow Autoregulation
Current Vascular Pharmacology The Challenges of Blood Pressure Control in Dialysis Patients
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Beneficial Extracardiac Effects of Cardiovascular Medications
Current Cardiology Reviews SPMMTE and HPLC Methods for the Analyses of Cardiovascular Drugs in Human Plasma Using New Generation C28 Column
Current Pharmaceutical Analysis Therapeutic Interventions in the Glyc(oxid)ation Pathway
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Hyperglycemia-Related Pathophysiologic Mechanisms and Potential Beneficial Actions of Melatonin
Mini-Reviews in Medicinal Chemistry G Protein-Coupled Receptor Fusion Proteins in Drug Discovery
Current Pharmaceutical Design Editorial (Should Chronic Kidney Disease be Considered as a Coronary Heart Disease Equivalent?)
Current Vascular Pharmacology The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
Current Molecular Pharmacology Class III Antiarrhythmics and Phenytoin: Teratogenicity Due to Embryonic Cardiac Dysrhythmia and Reoxygenation Damage
Current Pharmaceutical Design N6-methyladenine RNA Modification (m<sup>6</sup>A): An Emerging Regulator of Metabolic Diseases
Current Drug Targets Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists
Current Drug Targets Bridging Differences in Outcomes of Pharmacoepidemiological Studies: Design and First Results of the PROTECT Project
Current Clinical Pharmacology Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias
Current Neuropharmacology